Short answer: Stacking means taking two or more compounds at the same time. Some pairs make sense on paper because they act on different pathways. The cost is that you can no longer tell which compound caused a benefit or a side effect. Add one compound at a time, a few weeks apart, and keep labs before and after each change.
People stack for two reasons: compounds that act on different pathways toward the same goal, or separate goals at the same time (for example, injury recovery and weight loss).
The trade-off is real. More compounds means more cost, more variables and side effects that are harder to trace. Know how each compound affects you on its own first.
| Stack | Reasoning | Evidence |
|---|---|---|
| CJC-1295 + ipamorelin | A GHRH-type peptide and a ghrelin-type peptide act on different receptors | Human studies show GHRH plus a GHRP releases more growth hormone than either alone; this exact pair has little trial data |
| BPC-157 + TB-500 | Both are studied for tissue repair | Mostly animal studies; no human trials of the pair |
| Growth hormone peptide + BPC-157 | Separate goals, no known overlap | No studies of the combination |
Ipamorelin was picked out early because, in animal studies, it raised growth hormone without raising cortisol or prolactin the way older peptides like GHRP-6 did (Raun 1998).
Check pairs in the interaction checker, and tell your prescriber and pharmacist everything you take.
If you start two compounds together and feel better, you do not know which one helped. If you feel worse, you do not know which one to stop.
So add one compound, keep the dose steady for a few weeks, log how you feel, then add the next. It is slower, and it is the only way to know what each one does for you.
People often draw two compatible peptides into one syringe right before injecting, such as CJC-1295 and ipamorelin. There is little published data on whether specific peptides are stable together, so do it only at injection time.
Do not combine two mixed peptides in one vial for storage. You cannot change the ratio later, and if one degrades or gets contaminated you lose both.
Log each compound separately so each has its own history.
| Marker | Why | Most relevant to |
|---|---|---|
| IGF-1 | Shows the growth hormone effect | Growth hormone peptides |
| Fasting glucose, HbA1c | Growth hormone can raise blood sugar; GLP-1 drugs lower it | Growth hormone peptides, GLP-1 drugs |
| Lipid panel | Can shift with hormone-related compounds | Long-term use, testosterone |
| CBC | General health; hematocrit | Testosterone, long-term use |
| Metabolic panel | Kidney and liver function | Anything long-term |
Get a panel before you start, then again after each change has settled. Then a change in your numbers points at one change in your plan.
See also: Interaction checker · Peptide blends · Set up a blend in Dose Track